FR2333511B1 - - Google Patents

Info

Publication number
FR2333511B1
FR2333511B1 FR7636343A FR7636343A FR2333511B1 FR 2333511 B1 FR2333511 B1 FR 2333511B1 FR 7636343 A FR7636343 A FR 7636343A FR 7636343 A FR7636343 A FR 7636343A FR 2333511 B1 FR2333511 B1 FR 2333511B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7636343A
Other versions
FR2333511A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2333511A1 publication Critical patent/FR2333511A1/fr
Application granted granted Critical
Publication of FR2333511B1 publication Critical patent/FR2333511B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7636343A 1975-12-05 1976-12-02 Nouveaux derives de dihydro-3,4 quinazoline et leurs procedes de preparation Granted FR2333511A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina

Publications (2)

Publication Number Publication Date
FR2333511A1 FR2333511A1 (fr) 1977-07-01
FR2333511B1 true FR2333511B1 (fr) 1979-03-02

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7636343A Granted FR2333511A1 (fr) 1975-12-05 1976-12-02 Nouveaux derives de dihydro-3,4 quinazoline et leurs procedes de preparation

Country Status (22)

Country Link
US (1) US4251531A (fr)
JP (1) JPS5271485A (fr)
AT (1) AT355029B (fr)
AU (1) AU505660B2 (fr)
BE (1) BE848696A (fr)
CA (1) CA1084051A (fr)
CH (2) CH626073A5 (fr)
CS (1) CS194786B2 (fr)
DE (1) DE2654215A1 (fr)
DK (1) DK147855C (fr)
FI (1) FI64359C (fr)
FR (1) FR2333511A1 (fr)
GB (1) GB1523081A (fr)
HU (1) HU177817B (fr)
IL (1) IL50849A (fr)
IT (1) IT1050750B (fr)
NL (1) NL7613450A (fr)
NO (1) NO146095C (fr)
NZ (1) NZ182778A (fr)
SE (1) SE7613588L (fr)
SU (1) SU786894A3 (fr)
ZA (1) ZA766745B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
JPS5925224U (ja) * 1982-08-10 1984-02-16 株式会社根来 かばん
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CA2332535C (fr) * 1998-05-22 2006-02-28 Abbott Laboratories Medicament anti-angiogenique pour le traitement du cancer, de l'arthrite et de la retinopathie
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
EP1389103A4 (fr) * 2001-04-23 2005-09-14 Univ Virginia Synthese et evaluation de nouvelles substances mimetiques de phthalimide comme agents antiangiogenese
CA2525383C (fr) * 2003-06-06 2012-03-06 Arexis Ab Utilisation de composes heterocycliques comme inhibiteurs de l'enzyme chymotryptique de la couche cornee
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
JP5193866B2 (ja) * 2006-08-08 2013-05-08 あすか製薬株式会社 キナゾリン誘導体
DK2118074T3 (en) 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
CA2992231C (fr) 2009-03-18 2022-03-29 Resverlogix Corp. Derives de la phenyl-quinazolin-4(3h)-one et de la phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one et leurs compositions utiles comme agents anti-inflammatoires
KR20190091564A (ko) 2009-04-22 2019-08-06 리스버로직스 코퍼레이션 신규한 소염제
KR102662814B1 (ko) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
MX2020014116A (es) 2018-06-27 2021-06-15 Reborna Biosciences Inc Agente profilactico o terapeutico para atrofia muscular espinal.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
ZA766745B (en) 1977-10-26
DE2654215A1 (de) 1977-06-16
AU505660B2 (en) 1979-11-29
IT1050750B (it) 1981-03-20
FI64359B (fi) 1983-07-29
ATA894376A (de) 1979-07-15
CH626075A5 (fr) 1981-10-30
IL50849A (en) 1980-11-30
DK546776A (da) 1977-06-06
AU1947276A (en) 1978-05-18
FI763391A (fr) 1977-06-06
FR2333511A1 (fr) 1977-07-01
NO146095B (no) 1982-04-19
IL50849A0 (en) 1977-01-31
DK147855B (da) 1984-12-24
GB1523081A (en) 1978-08-31
CA1084051A (fr) 1980-08-19
SE7613588L (sv) 1977-06-06
NL7613450A (nl) 1977-06-07
NO764135L (fr) 1977-06-07
SU786894A3 (ru) 1980-12-07
US4251531A (en) 1981-02-17
CS194786B2 (en) 1979-12-31
HU177817B (en) 1981-12-28
CH626073A5 (fr) 1981-10-30
NZ182778A (en) 1978-07-28
JPS5543464B2 (fr) 1980-11-06
DK147855C (da) 1985-06-10
FI64359C (fi) 1983-11-10
NO146095C (no) 1982-08-11
AT355029B (de) 1980-02-11
BE848696A (fr) 1977-03-16
JPS5271485A (en) 1977-06-14

Similar Documents

Publication Publication Date Title
JPS5347289B2 (fr)
FR2333511B1 (fr)
FR2323904B1 (fr)
FR2314325B2 (fr)
JPS5517016B2 (fr)
JPS5320456B2 (fr)
JPS5290718U (fr)
JPS5263527U (fr)
JPS51107815A (fr)
JPS5191362A (fr)
JPS5550905Y2 (fr)
JPS5279816U (fr)
JPS5255444U (fr)
JPS5213968U (fr)
JPS5231136U (fr)
CH604662A5 (fr)
CH598492A5 (fr)
CH601792A5 (fr)
CH600784A5 (fr)
CH600683A5 (fr)
CH600537A5 (fr)
CH603717A5 (fr)
CH600349A5 (fr)
CH600331A5 (fr)
CH599232A5 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse